Candel Therapeutics Inc (CADL NASDAQ) stock market data APIs
$10.0578
-0.14(-1.4%)
as of July 6, 2026
Try our APIs with
free plan!
Candel Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
Prev. Close
10.0578
Open
9.9143
High
10.4086
Low
9.8967
52 wk Range
4.35-11.3599
Market Cap
720 M
Shares Outstanding
73 270 K
Revenue
31 000
EPS
-0.14
Beta
-0.511
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Candel Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Candel Therapeutics Inc data using free add-ons & libraries
Get Candel Therapeutics Inc Fundamental Data
Candel Therapeutics Inc Fundamental data includes:
- Net Revenue: 31 000
- EBITDA: -55 581 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: -0.2094
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Candel Therapeutics Inc News
New
5 Biotech Stocks That Skyrocketed 105% To 235% — TWST, INDV, MIRM & More
(RTTNews) - "To be a successful business owner and investor, you have to be emotionally neutral to winning and losing. Winning and losing are just part of the game," said Robert Kiyosaki, American ent...
Candel Therapeutics Designates Mark Sims as CCO
By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said it appointed Mark Sims as Chief Commercial Officer effective July 6, 2026, having previously served at AstraZeneca as Vice President and G...
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEEDHAM, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immuno...
Candel Therapeutics GAAP EPS of -$0.14 beats by $0.19
* Candel Therapeutics press release [https://seekingalpha.com/pr/20515327-candel-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate] (CADL [https://seekingalpha.com/symbo...
Get Candel Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
